Sentinel lymph node biopsy for cutaneous head and neck melanomas.
Sentinel lymph node biopsy for cutaneous head and neck melanomas.
复制标题
头颈部皮肤黑色素瘤的前哨淋巴结活检。
DOI:
--
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
D. Kraus
中科院分区:
文献类型:
--
作者:
S. Patel;D. Coit;A. Shaha;M. Brady;J. Boyle;Bhuvanesh Singh;J. Shah;D. Kraus
OBJECTIVE
To report the results of sentinel lymph node biopsy (SLNB) for cutaneous head and neck melanomas (CMHNs).
DESIGN
Consecutive series followed for a median of 20 months.
SETTING
Tertiary cancer care center.
PATIENTS
Fifty-six individuals with clinically node-negative CMHN, median Breslow thickness, 2.6 mm (range, 0.2-20.0 mm).
INTERVENTIONS
Preoperative technetium 99m sulfur colloid lymphoscintigraphy (PLSG) followed within 4 hours by intraoperative handheld gamma probe localization (IHGP). Intraoperative injection of 1% isosulfan blue dye (IBD) was used in 48 patients. Immediate completion nodal dissection was performed for metastatic SLNs on intraoperative frozen section analysis and monitoring for negative SLNs.
MAIN OUTCOME MEASURES
Rate of SLN identification, SLN and non-SLN positivity, same-basin recurrence, and disease-specific and recurrence-free survival.
RESULTS
Combination of IHGP and IBD improved SLN identification to 96% from 93% for IHGP and 73% for IBD alone. Four patients had a positive SLN on frozen section analysis. A negative SLNB correctly predicted regional nodal control in 47 of 48 patients but missed 1 of 5 patients who had regional lymphatic disease. All 4 patients who failed SLNB remain alive and free of recurrent disease. Two-year Kaplan-Meier disease-specific and relapse-free survival was 91% and 88%, respectively. Two-year disease-specific survival was 93% for SLN-negative patients and 50% for SLN-positive patients (P=.20).
CONCLUSIONS
Combining PLSG with IHGP and IBD improves the success rate of SLNB. Although SLNB is a reliable indicator of the status of the draining lymphatic basins in CMHN, patients with negative SLNs must be observed for longer periods to understand the true implications of the procedure.
影响因子:
5.2
作者:
Kelemen,PR;Essner,R;Foshag,LJ;Morton,DL
通讯作者:
Morton,DL
DOI:
--
发表时间:
1998
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Glass,EC;Essner,R;Morton,DL
通讯作者:
Morton,DL